Patent Trial and Appeal Board institutes review of Merck's US Patent No. 7,713,947
In assessing a petition for inter partes review of claims 36, 38, 39, and 41-46 of Merck Serono S.A.'s US patent No. 7,713,947, the Patent Trial and Appeal Board finds that generic drugmaker...To view the full article, register now.
Already a subscriber? Click here to view full article